cro.directory
Home
Voiant logo

Voiant

Industry-leading imaging CRO with 30+ years of expertise and AI-powered endpoint adjudication.

Voiant is the industry-leading imaging CRO for clinical trial imaging and endpoint adjudication, leveraging 30+ years of clinical expertise and AI-powered technology to deliver high-quality endpoint data across Phase I–IV global trials.

Phases

Services

About this organization

Overview

Voiant is a specialized clinical research organization focused on clinical trial imaging and endpoint adjudication. The company combines three decades of clinical imaging expertise with proprietary AI-powered technology to accelerate imaging processing and analysis.

Core Capabilities

  • Clinical Trial Imaging & Endpoint Adjudication: Industry-leading expertise in imaging endpoint data across Phase I–IV trials
  • AI-Powered Platform: Purpose-built technology to accelerate imaging processing and analysis with industry-leading turnaround times
  • Global Trial Support: Experience across multiple therapeutic areas with a global network of imaging experts
  • Scientific Accuracy: Renowned scientists and imaging specialists delivering differentiated expertise

Track Record

Voiant has processed billions of images across successful trials spanning multiple therapeutic areas, with experience supporting numerous drug approvals. The company operates across multiple countries and serves a broad client base in clinical development.

Similar profiles by shared services, phases, and indications.

Submit a verified review for this organization.

Markdown mirror: /companies/voiantclinical.md